MedTech News
.................... by Andrew Celentano
Personalized disease-in-a-dish can improve a pancreatitis patient’s therapeutic path
In a new study published in Cell Stem Cell, the researchers developed a patient-derived organoid platform to uncover how chronic pancreatitis develops at the molecular level and identify possible therapeutic strategies.
New mechanism behind breast cancer metastasis uncovered
In the new study, the researchers show that METTL3 in breast cancer cells relocates from its usual location in the nucleus to the cytoplasm.
New T‑cell therapy targets three tumor proteins, shows early survival gains in aggressive pediatric brain cancers
Researchers report encouraging early results from a first-in-human clinical trial led by Children’s National Hospital using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors.
Lab-grown retinal cells show promise for new eye therapies
Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.
Brain–computer interface detects hidden awareness in unresponsive patients
A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has been demonstrated by researchers at the University of Bath in the U.K.
A blood protein can flag dementia risk decades before symptoms appear
A recent study found that a blood protein called GDF15, which is released when cells are under stress, could serve as one of the earliest warning signs of dementia.
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Rare Powassan Virus Can Lead to Serious Brain or Spinal Cord Inflammation, and Cases are Rising in the U.S.
Powassan virus spreads through infected ticks, raising concern in Maine and Rhode Island, and symptoms can make the infection dangerous.